Strong Covid-19 vaccine booster data from Pfizer likely to encourage broader use, says Fitch
KUALA LUMPUR (Oct 28): Clinical data showing a third dose of Pfizer-BioNTech’s Covid-19 vaccine strongly increased protection against symptomatic Covid-19 will encourage countries to progress with booster dose campaigns, said Fitch Solutions Country Risk and Industry Research.